- Home
- Products
- Customized FluoroAb™
- GUCY2C
- Anti-GUCY2C MAb (Clone 1)-iFluor® 450 Succinimidyl Ester
Anti-GUCY2C MAb (Clone 1)-iFluor® 450 Succinimidyl Ester (CAT#: WJY0-LS6494)
- TARGET
- ANTIBODY
- DYE
- Name
- GUCY2C
- Alternative Names
- GUCY2C; DIAR6; GUC2C; MECIL; MUCIL; STAR; guanylate cyclase 2C; GC-C
- Overview
- Anti-GUCY2C antibody (Clone 1)
- Species Reactivity
- Human
- Name
- iFluor® 450 Succinimidyl Ester
- Color
- Green
- Excitation⁄Emission (nm)
- 451/502
- Detection method
- Fluorescent
Published Data
+ Submit Publications
Scientific Resources
Customer Reviews and FAQs
There are currently no Customer reviews or questions for WJY0-LS6494. Click the button above to contact us or submit your feedback about this product.
Quick Links
Other Products
Same Target
| CAT# | Product Name | Linker | Payload |
| ADC-W-210 | Anti-GUCY2C-Mc-MMAF ADC | Mc (maleimidocaproyl) | MMAF (Monomethyl auristatin F) |
| ADC-W-209 | Anti-GUCY2C-VC-MMAE ADC | VC (valine-citrulline) | MMAE (Monomethyl auristatin E) |
| ADC-W-403 | Anti-GUCY2C-MMAE ADC | Cleavable peptide linker | MMAE (Monomethyl auristatin E) |
For Research Use Only. NOT FOR CLINICAL USE.
Related Products
- Anti-GD2 MAb (Clone 3)-iFluor® 555 Succinimidyl Ester (CAT#: WJY0-LS16955)
- Anti-CEACAM5 MAb (Clone 11)-iFluor® 514 Succinimidyl Ester (CAT#: WJY0-LS11806)
- Anti-SLC44A4 MAb (Clone 2)-iFluor® 514 Succinimidyl Ester (CAT#: WJY0-LS11220)
- Anti-FGFR2 MAb (Clone 10)-iFluor® 460 Succinimidyl Ester (CAT#: WJY0-LS7950)
- Anti-MSTN MAb (Clone 8)-iFluor® 514 Succinimidyl Ester (CAT#: WJY0-LS12193)
- Anti-CD6 MAb (Clone 8)-iFluor® 532 Succinimidyl Ester (CAT#: WJY0-LS13513)
- Anti-CD70 MAb (Clone 6)-iFluor® 440 Succinimidyl Ester (CAT#: WJY0-LS5066)
- Radretumab-PBlue (CAT#: ADC-FL-1512)
- Anti-CD40LG MAb (Clone 3)-iFluor® 532 Succinimidyl Ester (CAT#: WJY0-LS12895)
- Anti-158P1D7 MAb (Clone 1)-iFluor® 546 Succinimidyl Ester (CAT#: WJY0-LS14074)
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
